(b)
REX American Resources Corporation
Pro Forma Consolidated (unaudited) Financial Information
On July 12, 2010, REX NuGen, LLC, a wholly owned subsidiary of REX American Resources Corporation (“REX” or “the Company”) completed the acquisition of Class A membership interest units of NuGen Energy, LLC (“NuGen”) from Central Farmers Cooperative (“CFC”) pursuant to the Unit Purchase and Option Agreement dated June 30, 2010 (the “Agreement”) among REX and CFC. The Class A Units constitute a 48.9% voting interest and a 47.77% equity interest in NuGen on a fully diluted basis.
The unaudited pro forma statements of income for the year ended January 31, 2010 and the three months ended April 30, 2010 are prepared as if the acquisition occurred at the beginning of the year ended January 31, 2010 (February 1, 2009). The unaudited pro forma balance sheet information as of April 30, 2010 has been prepared as if the acquisition occurred on that date.
The unaudited pro forma consolidated financial information has been derived from the application of pro forma adjustments to the historical consolidated financial statements of the Company and NuGen. The unaudited pro forma financial information is presented for illustrative purposes only and is not necessarily indicative of the financial position or results of operations that would have actually been reported had the acquisition occurred as of the beginning of the periods presented or at the balance sheet date presented, nor is it necessarily indicative of future financial position or results of operations. The pro forma adjustments give effect to the preliminary estimated allocation of the acquisition purchase price. This unaudited pro forma financial information does not include, nor does it assume, any benefits from cost savings or synergies of the equity investment. The pro forma adjustments are based upon available information and certain assumptions we believe are reasonable.
The unaudited pro forma consolidated financial information includes historical financial information for the Company and NuGen. The Company’s historical consolidated balance sheet as of April 30, 2010 and its historical consolidated statement of operations for the three months ended April 30, 2010 were taken from the unaudited consolidated financial statements in the Company’s quarterly report on Form 10-Q for the quarter ended April 30, 2010. The Company’s historical consolidated statement of operations for the year ended January 31, 2010 was taken from the audited consolidated financial statements in the Company’s most recent annual report on Form 10-K for the year ended January 31, 2010.
Information related to NuGen’s historical balance sheet used to determine the investment value as of April 30, 2010 was derived from NuGen’s unaudited balance sheet as of April 30, 2010 not included in this Form 8-K/A. Information related to NuGen’s historical statement of income for the year ended January 31, 2010 for inclusion in the consolidated pro forma statements of operations was derived from NuGen’s unaudited statement of income for the year ended July 31, 2010 not included in this Form 8-K/A. Information related to NuGen’s historical statement of income for the three months ended April 30, 2010 was derived from its unaudited statement of income for the three months ended April 30, 2010 not included in this Form 8-K/A.
The preliminary purchase price of approximately $13.8 million includes contingent consideration to the seller with an estimated fair value of approximately $4.6 million, which was based upon future cash distributions from NuGen that the Company is entitled to. The proceeds paid at closing of $9.2 million were paid out of the Company’s cash holdings and no debt was issued in connection with the acquisition. The purchase price has been allocated on a preliminary basis to assets acquired and liabilities assumed based on the estimated fair value as of the date of acquisition. This allocation resulted in the book basis of fixed assets being increased for purposes of pro forma presentation. Thus, additional depreciation expense was taken in the pro forma financial statements for the “step up” of fixed assets. Furthermore, the Company determined that it does not have a controlling interest in NuGen; therefore, the Company uses the equity method of accounting for its share of NuGen’s results of operations.
The unaudited pro forma financial information should be read in conjunction with the historical consolidated financial statements and notes thereto of the Company included on Form 10-Q for the quarters ended April 30, 2010 and July 31, 2010 and Form 10-K for the year ended January 31, 2010 and with the historical audited financial statements of NuGen for the ten months ended May 31, 2009 included in this Form 8-K/A.
PF-1
REX AMERICAN RESOURCES CORPORATION AND SUBSIDIARIES
Consolidated Pro Forma Balance Sheets
Unaudited
| | | | | | | | | | |
| | REX Historical April 30, 2010 | | Investment in 48% Interest in NuGen (1) | | Pro Forma April 30, 2010 | |
| |
| | | |
| |
| | | (In Thousands) | |
Assets | | | | | | | | | | |
Current assets: | | | | | | | | | | |
Cash and cash equivalents | | $ | 101,420 | | $ | (9,215 | ) | $ | 92,205 | |
Accounts receivable, net | | | 7,460 | | | — | | | 7,460 | |
Inventory, net | | | 7,430 | | | — | | | 7,430 | |
Refundable income taxes | | | 6,240 | | | — | | | 6,240 | |
Prepaid expenses and other | | | 2,751 | | | — | | | 2,751 | |
Deferred taxes, net | | | 5,138 | | | — | | | 5,138 | |
| |
|
| |
|
| |
|
| |
Total current assets | | | 130,439 | | | (9,215 | ) | | 121,224 | |
Property and equipment, net | | | 242,345 | | | — | | | 242,345 | |
Other assets | | | 9,517 | | | — | | | 9,517 | |
Deferred taxes, net | | | 8,480 | | | — | | | 8,480 | |
Equity method investments | | | 46,081 | | | 13,826 | | | 59,907 | |
Investments in debt instruments | | | 514 | | | — | | | 514 | |
Restricted investments and deposits | | | 2,100 | | | — | | | 2,100 | |
| |
|
| |
|
| |
|
| |
Total assets | | $ | 439,476 | | $ | 4,611 | | $ | 444,087 | |
| |
|
| |
|
| |
|
| |
Liabilities and equity: | | | | | | | | | | |
Current liabilities: | | | | | | | | | | |
Current portion of long-term debt and capital lease obligations, alternative energy | | $ | 13,397 | | $ | — | | $ | 13,397 | |
Current portion of long-term debt, other | | | 323 | | | — | | | 323 | |
Accounts payable, trade | | | 5,642 | | | — | | | 5,642 | |
Deferred income | | | 6,772 | | | — | | | 6,772 | |
Accrued restructuring charges | | | 502 | | | — | | | 502 | |
Accrued real estate taxes | | | 1,815 | | | — | | | 1,815 | |
Derivative financial instruments | | | 1,749 | | | — | | | 1,749 | |
Other current liabilities | | | 5,324 | | | 374 | | | 5,698 | |
| |
|
| |
|
| |
|
| |
Total current liabilities | | | 35,524 | | | 374 | | | 35,898 | |
| |
|
| |
|
| |
|
| |
Long-term liabilities: | | | | | | | | | | |
Long-term debt and capital lease obligations, alternative energy | | | 110,716 | | | — | | | 110,716 | |
Long-term debt, other | | | 2,182 | | | — | | | 2,182 | |
Deferred income | | | 5,122 | | | — | | | 5,122 | |
Derivative financial instruments | | | 3,946 | | | — | | | 3,946 | |
Other | | | 575 | | | 4,237 | | | 4,812 | |
| |
|
| |
|
| |
|
| |
Total long-term liabilities | | | 122,541 | | | 4,237 | | | 126,778 | |
| |
|
| |
|
| |
|
| |
Equity: | | | | | | | | | | |
REX shareholders’ equity: | | | | | | | | | | |
Common stock | | | 299 | | | — | | | 299 | |
Paid-in capital | | | 142,120 | | | — | | | 142,120 | |
Retained earnings | | | 295,172 | | | — | | | 295,172 | |
Treasury stock | | | (186,097 | ) | | — | | | (186,097 | ) |
Accumulated other comprehensive income, net of tax | | | 27 | | | — | | | 27 | |
| |
|
| |
|
| |
|
| |
Total REX shareholders’ equity | | | 251,521 | | | — | | | 251,521 | |
Noncontrolling interests | | | 29,890 | | | — | | | 29,890 | |
| |
|
| |
|
| |
|
| |
Total equity | | | 281,411 | | | — | | | 281,411 | |
| |
|
| |
|
| |
|
| |
Total liabilities and equity | | $ | 439,476 | | $ | 4,611 | | $ | 444,087 | |
| |
|
| |
|
| |
|
| |
PF-2
REX AMERICAN RESOURCES CORPORATION AND SUBSIDIARIES
Consolidated Pro Forma Statements Of Operations
Unaudited
| | | | | | | | | | |
| | REX Historical Three Months Ended April 30, 2010 | | Investment in 48% Interest in NuGen (2, 3) | | Pro Forma Three Months Ended April 30, 2010 | |
| |
| | | |
| |
| | | | | | | | | | |
Net sales and revenue | | $ | 71,291 | | $ | — | | $ | 71,291 | |
Cost of sales | | | 63,194 | | | — | | | 63,194 | |
| |
|
| |
|
| |
|
| |
| | | | | | | | | | |
Gross profit | | | 8,097 | | | — | | | 8,097 | |
Selling, general and administrative expenses | | | (2,093 | ) | | — | | | (2,093 | ) |
Interest income | | | 115 | | | — | | | 115 | |
Interest expense | | | (1,367 | ) | | — | | | (1,367 | ) |
Equity in income (loss) of unconsolidated ethanol affiliates | | | 2,847 | | | (176 | ) | | 2,671 | |
Losses on derivative financial instruments, net | | | (167 | ) | | — | | | (167 | ) |
| |
|
| |
|
| |
|
| |
Income (loss) from continuing operations before provision/benefit for income taxes and discontinued operations | | | 7,432 | | | (176 | ) | | 7,256 | |
(Provision) benefit for income taxes | | | (2,484 | ) | | 70 | | | (2,414 | ) |
| |
|
| |
|
| |
|
| |
Income (loss) from continuing operations including noncontrolling interests | | | 4,948 | | | (106 | ) | | 4,842 | |
Income from discontinued operations, net of tax | | | 657 | | | — | | | 657 | |
| |
|
| |
|
| |
|
| |
Net income (loss) including noncontrolling interests | | | 5,605 | | | (106 | ) | | 5,499 | |
Net loss (income) attributable to noncontrolling interests | | | (1,417 | ) | | — | | | (1,417 | ) |
| |
|
| |
|
| |
|
| |
Net income (loss) attributable to REX common shareholders | | $ | 4,188 | | $ | (106 | ) | $ | 4,082 | |
| |
|
| |
|
| |
|
| |
| | | | | | | | | | |
Weighted average shares outstanding – basic | | | 9,840 | | | | | | 9,840 | |
| |
|
| | | | |
|
| |
| | | | | | | | | | |
Basic income (loss) per share from continuing operations attributable to REX common shareholders | | $ | 0.36 | | | | | $ | 0.35 | |
Basic income per share from discontinued operations attributable to REX common shareholders | | | 0.07 | | | | | | 0.07 | |
| |
|
| | | | |
|
| |
Basic net income (loss) per share attributable to REX common shareholders | | $ | 0.43 | | | | | $ | 0.42 | |
| |
|
| | | | |
|
| |
| | | | | | | | | | |
Weighted average shares outstanding – diluted | | | 10,045 | | | | | | 10,045 | |
| |
|
| | | | |
|
| |
| | | | | | | | | | |
Diluted income (loss) per share from continuing operations attributable to REX common shareholders | | $ | 0.35 | | | | | $ | 0.34 | |
Diluted income per share from discontinued operations attributable to REX common shareholders | | | 0.07 | | | | | | 0.07 | |
| |
|
| | | | |
|
| |
Diluted net income (loss) per share attributable to REX common shareholders | | $ | 0.42 | | | | | $ | 0.41 | |
| |
|
| | | | |
|
| |
| | | | | | | | | | |
Amounts attributable to REX common shareholders: | | | | | | | | | | |
Income (loss) from continuing operations, net of tax | | $ | 3,531 | | $ | (106 | ) | $ | 3,425 | |
Income from discontinued operations, net of tax | | | 657 | | | — | | | 657 | |
| |
|
| |
|
| |
|
| |
Net income (loss) | | $ | 4,188 | | $ | (106 | ) | $ | 4,082 | |
| |
|
| |
|
| |
|
| |
PF-3
REX AMERICAN RESOURCES CORPORATION AND SUBSIDIARIES
Consolidated Pro Forma Statements Of Operations
Unaudited
| | | | | | | | | | |
| | REX Historical Year Ended January 31, 2010 | | Investment in 48% Interest in NuGen (2, 4) | | Pro Forma Year Ended January 31, 2010 | |
| |
| | | |
| |
| | | | | | | | | | |
Net sales and revenue | | $ | 170,264 | | $ | — | | $ | 170,264 | |
Cost of sales | | | 150,531 | | | — | | | 150,531 | |
| |
|
| |
|
| |
|
| |
Gross profit | | | 19,733 | | | — | | | 19,733 | |
Selling, general and administrative expenses | | | (6,025 | ) | | — | | | (6,025 | ) |
Interest income | | | 445 | | | — | | | 445 | |
Interest expense | | | (4,741 | ) | | — | | | (4,741 | ) |
Loss on early termination of debt | | | (89 | ) | | — | | | (89 | ) |
Equity in income of unconsolidated ethanol affiliates | | | 6,027 | | | 4,199 | | | 10,226 | |
Other income | | | 748 | | | — | | | 748 | |
Losses on derivative financial instruments, net | | | (2,487 | ) | | — | | | (2,487 | ) |
| |
|
| |
|
| |
|
| |
Income from continuing operations before provision for income taxes and discontinued operations | | | 13,611 | | | 4,199 | | | 17,810 | |
Provision for income taxes | | | (4,553 | ) | | (1,680 | ) | | (6,233 | ) |
| |
|
| |
|
| |
|
| |
Income from continuing operations including noncontrolling interests | | | 9,058 | | | 2,519 | | | 11,577 | |
Income from discontinued operations, net of tax | | | 2,120 | | | — | | | 2,120 | |
Gain on disposal of discontinued operations, net of tax | | | 1,374 | | | — | | | 1,374 | |
| |
|
| |
|
| |
|
| |
Net income including noncontrolling interests | | | 12,552 | | | 2,519 | | | 15,071 | |
Net income attributable to noncontrolling interests | | | (3,900 | ) | | — | | | (3,900 | ) |
| |
|
| |
|
| |
|
| |
Net income (loss) attributable to REX common shareholders | | $ | 8,652 | | $ | 2,519 | | $ | 11,171 | |
| |
|
| |
|
| |
|
| |
| | | | | | | | | | |
Weighted average shares outstanding – basic | | | 9,254 | | | | | | 9,254 | |
| |
|
| | | | |
|
| |
| | | | | | | | | | |
Basic income per share from continuing operations attributable to REX common shareholders | | $ | 0.55 | | | | | $ | 0.83 | |
Basic income per share from discontinued operations attributable to REX common shareholders | | | 0.23 | | | | | | 0.23 | |
Basic income per share on disposal of discontinued operations attributable to REX common shareholders | | | 0.15 | | | | | | 0.15 | |
| |
|
| | | | |
|
| |
Basic net income per share attributable to REX common shareholders | | $ | 0.93 | | | | | $ | 1.21 | |
| |
|
| | | | |
|
| |
| | | | | | | | | | |
Weighted average shares outstanding – diluted | | | 9,551 | | | | | | 9,551 | |
| |
|
| | | | |
|
| |
| | | | | | | | | | |
Diluted income per share from continuing operations attributable to REX common shareholders | | $ | 0.54 | | | | | $ | 0.80 | |
Diluted income per share from discontinued operations attributable to REX common shareholders | | | 0.22 | | | | | | 0.22 | |
Diluted income per share on disposal of discontinued operations attributable to REX common shareholders | | | 0.15 | | | | | | 0.15 | |
| |
|
| | | | |
|
| |
Diluted net income per share attributable to REX common shareholders | | $ | 0.91 | | | | | $ | 1.17 | |
| |
|
| | | | |
|
| |
| | | | | | | | | | |
Amounts attributable to REX common shareholders: | | | | | | | | | | |
Income from continuing operations, net of tax | | $ | 5,158 | | $ | 2,519 | | $ | 7,677 | |
Income from discontinued operations, net of tax | | | 3,494 | | | — | | | 3,494 | |
| |
|
| |
|
| |
|
| |
Net income | | $ | 8,652 | | $ | 2,519 | | $ | 11,171 | |
| |
|
| |
|
| |
|
| |
PF-4
REX AMERICAN RESOURCES CORPORATION AND SUBSIDIARIES
Notes to Pro Forma Consolidated Financial Information (unaudited)
Note 1 Represents the acquisition of the 48% interest in NuGen (amounts in thousands):
| | | | |
Cash paid at closing | | $ | 9,215 | |
Fair value of contingent consideration | | | 4,611 | |
| |
|
| |
Total fair value of acquisition | | $ | 13,826 | |
| |
|
| |
Note 2 The fair value of the consideration, $13,826,000 exceeded 48% of NuGen’s net assets at the acquisition date by approximately $9,627,000. This excess was allocated to the carrying value of fixed assets, as the fair value of other assets and liabilities approximated the book value at the acquisition date. Depreciation expense on this step up of fixed assets is included as a pro forma adjustment.
Note 3 Represents the impact of REX’s share of NuGen’s loss for the quarter ended April 30, 2010 (amounts in thousands):
| | | | |
Loss of NuGen for the quarter | | $ | (32 | ) |
| |
|
| |
| | | | |
REX’s share of (at 48%): | | | | |
NuGen loss | | $ | (15 | ) |
Depreciation expense for step up of fixed assets | | | (161 | ) |
| |
|
| |
Pre tax loss | | | (176 | ) |
Benefit for income taxes (40% statutory rate) | | | 70 | |
| |
|
| |
Net loss | | $ | (106 | ) |
| |
|
| |
Note 4 Represents the impact of REX’s share of NuGen’s income for the year ended January 31, 2010 (amounts in thousands):
| | | | |
Income of NuGen for the year | | $ | 10,086 | |
| |
|
| |
| | | | |
REX’s share of (at 48%): | | | | |
NuGen income | | $ | 4,841 | |
Depreciation expense for step up of fixed assets | | | (642 | ) |
| |
|
| |
Pre tax income | | | 4,199 | |
Provision for income taxes (40% statutory rate) | | | (1,680 | ) |
| |
|
| |
Net income | | $ | 2,519 | |
| |
|
| |
PF-5
| | |
| | |
Exhibit No. | | Description of Exhibit |
| |
|
| | |
23 | | Consent of Independent Auditors |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | |
| | REX AMERICAN RESOURCES CORPORATION |
| | | |
Date: September 24, 2010 | By: | /s/ DOUGLAS L. BRUGGEMAN |
| |
|
| | Name: | Douglas L. Bruggeman |
| | Title: | Vice President - Finance, |
| | | Chief Financial Officer |
| | | and Treasurer |